Serotonin as a research platform for new drug discovery.
Phebus
L A
LA
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. lphebus@lilly.com
Schaus
J M
JM
D000818:Animals; D015195:Drug Design; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology; D009422:Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D018377:Neurotransmitter Agents; D011985:Receptors, Serotonin / Q000145:classification / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D018490:Serotonin Agents / Q000627:therapeutic use
D018377:Neurotransmitter Agents; D011985:Receptors, Serotonin; D018490:Serotonin Agents; D012701:Serotonin